About $20 billion in partnership deal value was committed to biotech last year, with about three-quarters of the dollars coming from pharmaceutical companies. Since 2004, the number of biotech deals has fallen somewhat, whereas value has bloomed. Deals for candidates at either end of the development pipeline were particularly popular last year, with more partnerships aimed at cancer, nervous system disorders and infectious diseases.

Number and value of biotech partnerships

Number of partnership deals by stage

Biotech R&D budgets with the largest increases

Biotech partnerships with big pharma

Number of partnerships by technology type

Number of partnerships by therapeutic area